<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Innovation

Research    Innovation

GOAL Consortium Facilitates Group Purchases and Knowledge Sharing for Academic Pathology Testing Labs

When Dara Aisner, MD, PhD, an associate professor in the Department of Pathology at the University of Colorado School of Medicine, was approached by a colleague at another university about splitting the cost of a bulk purchase of new clinical testing products, she initially declined. Although it would be a valuable resource — and might even save her lab money in the long-term — the short-term cost was prohibitive.


Author Valerie Gleaton | Publish Date September 07, 2021
Full Story

Innovation    Patient Care    Pancreatic Cancer    Surgical Oncology

Robotic Whipple Procedure Offers Pancreatitis Patient Relief

After suffering from painful bouts of pancreatitis for more than a decade, Christina Gonzalez felt resigned to a seemingly endless cycle of procedures.


Author Valerie Gleaton | Publish Date August 31, 2021
Full Story

Innovation    Melanoma

A New Drug Combination to Treat Mucosal Melanomas

Though people most often think of melanoma as affecting the skin, the cancer can occur anywhere in the body where pigment-producing melanocyte cells are found. That includes mucous membranes in the head, neck, eyes, respiratory tract, and genitourinary region.


Author Greg Glasgow | Publish Date June 23, 2021
Full Story

Research    Innovation

Sean Davis to Lead Health Data Science and AI Efforts for CU Cancer Center

A 13-year veteran of the National Cancer Institute (NCI) is coming to the University of Colorado Cancer Center to help lead efforts to develop and apply data science and artificial intelligence and methods to advance research and improve clinical practice.


Author Greg Glasgow | Publish Date December 30, 2020
Full Story

Innovation    COVID-19

CU Mass Spectrometry Shared Resource works to predict embolism in COVID-19

One of the major complications of severe COVID-19 is blood clots in the lungs – a pulmonary embolism that can block lung function leading to death. In fact, these blockages are similar to those from chronic heart disease, stroke, and even traumatic injuries like a car crash or gunshot wound. In these non-COVID-19 conditions, doctors use drugs to break up and dissolve the clotted blood. Now a team led by Colorado trauma surgeon Gene Moore, MD, is testing a similar approach against the dangerous blood clots associated with COVID-19.


Author Cancer Center | Publish Date May 19, 2020
Full Story

Research    Innovation

Colorado study overturns ‘snapshot’ model of cell cycle in use since 1974

Cells have a big decision: Should they replicate or sleep? Healthy cells can go either way. Cancer cells’ replication switches are stuck in the ‘on’ position. Now a study by University of Colorado Cancer Center researchers working at CU Boulder’s BioFrontiers Institute and published today in the journal Science overturns the conventional wisdom of how these switches work – a model accepted since 1974 and included in current textbooks. 


Author Cancer Center | Publish Date April 02, 2020
Full Story

Research    Innovation

CU Cancer Center project makes big data analysis accessible to Anschutz Campus researchers

Biomedical research can generate big data and it takes big brains running big computers to make any sense of it. For University of Colorado Cancer Center investigators, the solution has been to enlist the bioinformatics expertise provided through the Biostatistics and Bioinformatics Shared Resource (BBSR). Led by Director James Costello, PhD, and Manager/Data Analyst Andrew Goodspeed, PhD, the team of five experts at the BBSR shakes and sifts numbers until meaning emerges. But despite BBSR expertise in data analysis, the researchers generating the data in the first place are often in the best position to define “meaning,” and sending data away for analysis can leave these experts one step removed from their own work. Also, there is only so much shaking and sifting the BBSR can do, leading to a bottleneck in the workflow of research: Data is being generated across the Anschutz Medical Campus faster than investigators can make sense of it.


Author Cancer Center | Publish Date December 05, 2019
Full Story

CU Cancer Center In the News

Targeted Oncology

Forsberg Explains How Selinexor Fits Into Sequencing Therapies in R/R Multiple Myeloma

news outletTargeted Oncology
Publish DateNovember 16, 2022

During a roundtable event, Peter Forsberg, MD, discussed data from several trials of selinexor in patients with relapsed/refractory multiple myeloma.

Full Story
Cancer Health

Pancreatic Cancer Survivor Shares a Message of Hope

news outletCancer Health
Publish DateNovember 15, 2022

November is Pancreatic Cancer Awareness Month. Laura Foote shares her story to bring hope and express gratitude.

Full Story
TIME

How Bladder Cancer Differs in Women and Younger Adults

news outletTIME
Publish DateNovember 15, 2022

Men are three to four times more likely than women to develop bladder cancer, but the disease tends to be deadlier in females. Why?

Full Story
Biospace

Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers

news outletBiospace
Publish DateNovember 14, 2022

New therapeutic addresses need in patients suffering with cold and refractory tumors.

Full Story